Results 101 to 110 of about 98,010,213 (261)
SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies.
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged during the current coronavirus disease 2019 (COVID-19) pandemic.
Andreas Wack (488046) +20 more
core +1 more source
Sun et al. report a self‐assembling trimeric subunit vaccine platform termed RHS, which integrates the JN.1 receptor‐binding domain (RBD) with the heptad repeat 1 (HR1), stem helix (SH), and heptad repeat 2 (HR2) regions. The SARS‐CoV‐2 RHS vaccine elicits variant‐reactive RBD‐specific antibodies and cross‐reactive SH‐specific antibodies against ...
Xikui Sun +18 more
wiley +1 more source
Testing for antibodies to SARS-CoV-2 [PDF]
Gill, Dipender, Ponsford, Mark J
openaire +2 more sources
Dual pKa Lipid Nanoparticles for Lung‐tropic mRNA Delivery and pH‐Programmed Endosomal Escape
Lipid nanoparticles’ bottleneck lies in low endosomal escape efficiency and liver‐dominant delivery after intravenous administration. To overcome these limitations, we present a stepwise pH‐programmed lipid nanoparticle system enabled by our newly synthesized ionizable lipid.
Seong Gi Lim +12 more
wiley +1 more source
BackgroundReports on the evaluation of immune responses to different COVID-19 vaccines are limited. Similarly, effects of age and gender have not been well explored as variables that could impact on the vaccine-induced antibody response.
Abdulfattah Adekunle Onifade +6 more
doaj +1 more source
Compared to E8, mTeSR1 culture downregulated WNT and TGF‑β signaling, and upregulated neural differentiation pathways, enhancing neural priming. Under skin organoid induction conditions, mTeSR1‑cultured hESCs generated organoids with significantly higher neuroepithelial differentiation.
Zhongliang Chen +7 more
wiley +1 more source
The ongoing emergence of new variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) underscores the urgent need for developing antivirals targeting both SARS‐CoV‐2 variants and related sarbecoviruses.
Rui Qiao +16 more
doaj +1 more source
Reporte N°14: Vigilancia activa de variantes de SARS-CoV-2 en la Provincia de Córdoba. Actualización al 8/2/2021 [PDF]
Participantes en este reporte: • Nodo de secuenciación de Córdoba del IPAVE-INTA-CIAP: Franco Fernández, Nathalie Marquez y Humberto Debat. • Nodo de secuenciación de EEA Rafaela-INTA-CONICET (Provincia de Santa Fe): Matías Irazoqui, Ariel Amadío ...
Gobierno de la Provincia de Córdoba. Ministerio de Salud. Laboratorio Central +4 more
core
The global coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spawned an ongoing demand for new research reagents and interventions.
Naphak Modhiran +37 more
core +1 more source
[A&T]MLN is a triple‐modal nanoplatform with siRNA‐loaded LN coated with hybrid ACE2/macrophage membrane. It blocks viral entry, neutralizes IL‐6/IL‐1β/TNF‐α, and delivers siRNA to suppress viral replication. In a murine lung injury model, it attenuates inflammation, offering a multi‐pronged strategy against SARS‐CoV‐2 variants and hyperinflammation ...
Hui Li +19 more
wiley +1 more source

